{"id":196257,"date":"2024-09-16T11:22:57","date_gmt":"2024-09-16T16:22:57","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2024\/09\/immunotherapy-drugs-extend-survival-for-patients-with-advanced-melanomas"},"modified":"2024-09-16T11:22:57","modified_gmt":"2024-09-16T16:22:57","slug":"immunotherapy-drugs-extend-survival-for-patients-with-advanced-melanomas","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2024\/09\/immunotherapy-drugs-extend-survival-for-patients-with-advanced-melanomas","title":{"rendered":"Immunotherapy Drugs Extend Survival for Patients With Advanced Melanomas"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/immunotherapy-drugs-extend-survival-for-patients-with-advanced-melanomas.jpg\"><\/a><\/p>\n<p>Key Takeaways Key Takeaways.<\/p>\n<p>Immune-focused drugs such as nivolumab and ipilimumab have greatly improved the survival of people battling advanced melanomasA new trial finds a combo of these drugs can help people survive at least six years, on average, and maybe moreNo new \u2018safety signals\u2019 from use of the drugs were noted over the decade-long trial.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Key Takeaways. Immune-focused drugs such as nivolumab and ipilimumab have greatly improved the survival of people battling advanced melanomasA new trial finds a combo of these drugs can help people survive at least six years, on average, and maybe moreNo new \u2018safety signals\u2019 from use of the drugs were noted over the decade-long [\u2026]<\/p>\n","protected":false},"author":511,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-196257","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/196257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/511"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=196257"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/196257\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=196257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=196257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=196257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}